Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
NYSE:EBS
Emergent Biosolutions (EBS) Stock Price & Analysis
1,020 Followers
EBS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.42 - $10.88
Previous Close$1.93
Volume151.50M
Average Volume (3M)3.09M
Market Cap
$100.75M
Enterprise Value$849.25M
Total Cash (Recent Filing)$111.70M
Total Debt (Recent Filing)$860.20M
Price to Earnings (P/E)-0.1
Beta1.40
Next Earnings
Jul 25, 2024EPS Estimate
-$0.93Last Dividend Ex-Date
Aug 01, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-14.84
Shares Outstanding52,203,433
10 Day Avg. Volume1,065,363
30 Day Avg. Volume3,094,522
Standard Deviation0.21
R-Squared0.10
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.19
Price to Sales (P/S)0.10
Price to Cash Flow (P/CF)0.80
P/FCF Ratio0.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.81
Enterprise Value/Gross Profit2.47
Enterprise Value/Ebitda-1.71
Forecast
1Y Price Target
$5.00Price Target Upside51.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Emergent Biosolutions News
PremiumCompany Announcements
Emergent Biosolutions Adjusts Contract Terms and Preps Q1 Report
PremiumCompany Announcements
Emergent BioSolutions Announces Restructuring and Cost-Saving Measures
Ownership Overview
44.13% Insiders
24.65% Mutual Funds
21.82% Other Institutional Investors
9.40% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EBS FAQ
What was Emergent Biosolutions’s price range in the past 12 months?
Emergent Biosolutions lowest stock price was $1.42 and its highest was $10.88 in the past 12 months.
What is Emergent Biosolutions’s market cap?
Currently, no data Available
When is Emergent Biosolutions’s upcoming earnings report date?
Emergent Biosolutions’s upcoming earnings report date is Jul 25, 2024 which is in 83 days.
How were Emergent Biosolutions’s earnings last quarter?
Emergent Biosolutions released its earnings results on May 01, 2024. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of -$0.98 by $1.57.
Is Emergent Biosolutions overvalued?
According to Wall Street analysts Emergent Biosolutions’s price is currently Undervalued.
Does Emergent Biosolutions pay dividends?
Emergent Biosolutions pays a Notavailable dividend of $1.85 which represents an annual dividend yield of N/A. See more information on Emergent Biosolutions dividends here
What is Emergent Biosolutions’s EPS estimate?
Emergent Biosolutions’s EPS estimate is -$0.93.
How many shares outstanding does Emergent Biosolutions have?
Emergent Biosolutions has 52,203,434 shares outstanding.
What happened to Emergent Biosolutions’s price movement after its last earnings report?
Emergent Biosolutions reported an EPS of $0.59 in its last earnings report, beating expectations of -$0.98. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Emergent Biosolutions?
Among the largest hedge funds holding Emergent Biosolutions’s share is Hotchkis & Wiley Capital Management LLC. It holds Emergent Biosolutions’s shares valued at 4M.
---
Emergent Biosolutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (51.52% Upside)
$5.00 (51.52% Upside)
Blogger Sentiment
Bullish
EBS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 757.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.3%
Last 30 Days ▼ 5.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.24%
12-Months-Change
Fundamentals
Return on Equity
-74.34%
Trailing 12-Months
Asset Growth
-42.05%
Trailing 12-Months
Company Description
Emergent Biosolutions
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.
---
EBS Company Deck
---
EBS Earnings Call
Q1 2024
0:00 / 0:00
---
EBS Stock 12 Months Forecast
Average Price Target
$5.00
▲(51.52% Upside)
Technical Analysis
Best Analysts Covering EBS
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-47.40%
reiterated a buy rating 22 days ago
Copying Robert Wasserman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.40% per trade.
---